Common Mistakes
    Dosing

    I Skipped 2 Weeks of GLP-1: How to Safely Restart

    Whether you ran out, forgot, or had a medical reason to pause, here is how to safely resume your semaglutide or tirzepatide.

    Last updated: March 18, 2026·14 min read

    Quick Answer

    After a 2-week gap, most patients can restart at their previous dose or one step lower. The key factor is how long you were established at your dose before the break. Always confirm with your prescriber, as individual situations vary. Do not restart at a higher dose than you were previously taking.

    Life happens. A pharmacy delay, a vacation without access to your medication, an illness, or simply forgetting to refill your prescription. Whatever the reason you missed two weeks of your semaglutide or tirzepatide injections, the most important thing now is getting back on track safely.

    Understanding the Pharmacology: Why 2 Weeks Matters

    To understand why the restart approach matters, you need to know how GLP-1 medications work in your body over time. Semaglutide has a half-life of approximately 7 days, meaning that one week after your last injection, about half the medication is still circulating. After two weeks (two half-lives), roughly 25% of the last dose remains active.

    This means that after a 2-week gap, you still have some medication in your system but not enough to maintain full therapeutic effect. Your GLP-1 receptors have begun to "reset" but have not fully returned to their pre-treatment baseline. This is why 2 weeks is generally considered the cutoff where most patients can restart without full retitration.

    Semaglutide Clearance Timeline

    Time Since Last DoseApprox. Drug RemainingRestart Approach
    1 week (missed 1 dose)~50%Resume normal dose
    2 weeks (missed 2 doses)~25%Same dose or one step back
    3 weeks (missed 3 doses)~12%Step back one dose level
    4 weeks (missed 4 doses)~6%Retitrate from lower dose
    6+ weeks<2%Full retitration likely needed

    Step-by-Step Restart Guide After 2 Weeks

    Your 2-Week Gap Restart Plan

    • Step 1: Contact your prescriber.

      A quick message or telehealth appointment to confirm the restart dose. Most providers can advise via the patient portal without a full visit.

    • Step 2: Determine your restart dose.

      If you were stable at your dose for 4+ weeks before the gap, you can likely restart at the same dose. If you were still titrating, step back one level. If you experienced significant GI side effects at your last dose, this is a good opportunity to step back.

    • Step 3: Resume on your original injection day.

      Restart on whatever day of the week was your injection day. This maintains your schedule and reduces confusion going forward.

    • Step 4: Prepare for reintroduction side effects.

      Even at your previous dose, expect some GI side effects similar to (though usually milder than) when you first started. Stock up on bland foods and stay hydrated.

    • Step 5: Monitor and report.

      Track your response over the next 1-2 weeks. If side effects are manageable, continue at this dose. If they are severe, contact your provider about stepping back.

    Dose-Specific Restart Guidance

    Semaglutide (Ozempic/Wegovy)

    • If you were on 0.25 mg: Restart at 0.25 mg. This is already the starting dose, so no step-back is possible.
    • If you were on 0.5 mg: Most providers restart at 0.5 mg after a 2-week gap. If concerned about side effects, restart at 0.25 mg for one week.
    • If you were on 1.0 mg: Restart at 1.0 mg or step back to 0.5 mg for 1-2 weeks.
    • If you were on 1.7 mg: Consider restarting at 1.0 mg for 1-2 weeks before returning to 1.7 mg.
    • If you were on 2.4 mg: Restart at 1.7 mg for 1-2 weeks, then resume 2.4 mg. The higher the dose, the more conservative the restart.

    Tirzepatide (Mounjaro/Zepbound)

    • If you were on 2.5 mg: Restart at 2.5 mg (starting dose).
    • If you were on 5 mg: Restart at 5 mg or step back to 2.5 mg for one week.
    • If you were on 7.5-10 mg: Consider dropping back one dose level for 1-2 weeks.
    • If you were on 12.5-15 mg: Step back one or two levels to give your body time to readjust.

    What to Expect When You Restart

    Restarting after a 2-week gap is not quite like starting for the first time, but it is also not seamless. Here is what most patients experience:

    First 48 Hours

    The most common restart symptom is nausea, which typically appears 6-24 hours after the injection. It is usually milder than what you experienced during initial titration because your body has some "memory" of the medication. Appetite suppression returns relatively quickly, often within the first day.

    First Week Back

    GI side effects tend to peak during the first 2-3 days and then subside. You may notice that your appetite suppression is slightly less robust than before the break, which is normal. Energy levels may fluctuate as your body readjusts. Any weight that crept up during the 2-week gap typically reverses within the first week or two back on medication.

    Weeks 2-4

    By the second week back, most patients report feeling back to their pre-break baseline in terms of appetite suppression and side effect profile. If you stepped back a dose, your provider will guide you on when to resume your previous dose or continue titrating up.

    Common Reasons for 2-Week Gaps (and How to Prevent Them)

    1. Pharmacy or Supply Issues

    GLP-1 shortages have affected many patients. To prevent supply gaps, refill your prescription 5-7 days before you run out, ask about 90-day fills, and confirm availability before you are out. If using compounded medication, maintain communication with your pharmacy about lead times.

    2. Travel

    International travel or trips where you could not bring your medication are common gap causes. Plan ahead: pack medication in carry-on luggage with a travel cooler, bring more doses than you think you will need, and research whether your telehealth provider can send prescriptions to pharmacies at your destination.

    3. Cost Issues

    If cost caused the gap, explore affordable alternatives. Compounded GLP-1 options are significantly less expensive than brand-name medications. HSA and FSA accounts can also reduce out-of-pocket costs.

    4. Medical Procedures or Illness

    Some surgeries and medical procedures require pausing GLP-1 medications. If this applies to you, work with your surgeon and prescriber to create a clear restart plan before the procedure.

    5. Simply Forgetting

    Use medication tracking apps, set weekly phone alarms, and keep your injection supplies in a visible location. Some patients find that linking their injection to a specific weekly routine (such as Sunday evening after dinner) improves adherence.

    Impact on Weight Loss Progress

    A 2-week gap will not undo your progress, but you should have realistic expectations:

    • Appetite increase: You will likely feel hungrier during the gap. This is the medication wearing off, not a personal failure.
    • Water weight fluctuation: You may see a 2-4 lb increase on the scale, primarily from water retention and food weight, not fat gain.
    • Metabolic effects persist: The metabolic improvements from GLP-1 treatment (insulin sensitivity, etc.) do not vanish overnight.
    • Quick recovery: Most patients return to their pre-gap weight within 1-2 weeks of restarting.
    • Long-term trajectory: A 2-week pause in a 6-12 month treatment course has minimal impact on overall weight loss results.

    When NOT to Restart on Your Own

    See Your Provider First If:

    • You stopped due to severe side effects (pancreatitis symptoms, allergic reaction)
    • You had surgery during the break, especially bariatric or abdominal surgery
    • You started new medications during the gap
    • You became pregnant or suspect pregnancy
    • You developed new medical conditions during the break
    • Your gap was longer than 4 weeks
    • You have kidney disease or your kidney function has changed

    Key Takeaways

    • A 2-week gap is manageable; most patients can restart at their previous dose or one step below
    • Some medication remains in your system for about 2 weeks after your last dose
    • Expect mild GI side effects upon restart, similar to initial titration but usually less intense
    • Contact your prescriber before restarting for personalized guidance
    • Weight fluctuations during the gap are mostly water weight and reverse quickly
    • For gaps longer than 4 weeks, plan to retitrate from a lower dose
    • Implement prevention strategies to avoid future gaps

    Medical Disclaimer: This article is for educational purposes only and is not a substitute for professional medical advice. Restart protocols vary based on individual health history, specific medication, and dose. Always consult your healthcare provider before restarting any GLP-1 medication after a treatment gap.

    Reliable GLP-1 Access Without Gaps

    Our program includes automatic refills and proactive supply management so you never miss a dose.

    Get Started Today

    Sources & References

    1. Wilding JPH et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. NEJM 2021;384:989-1002.
    2. Jastreboff AM et al. Tirzepatide Once Weekly for the Treatment of Obesity. NEJM 2022;387:205-216.
    3. Lincoff AM et al. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. NEJM 2023;389:2221-2232.
    4. FDA Prescribing Information for Wegovy (semaglutide) and Zepbound (tirzepatide).

    Medically Reviewed

    TMRT

    Trimi Medical Review Team

    Clinical review workflow for GLP-1 safety, dosing, and access content

    Team-based medical review process documented in Trimi's Medical Review Policy

    Last reviewed: April 7, 2026

    TCCT

    Written by Trimi Clinical Content Team

    Medical Writers & Healthcare Professionals

    Our clinical content team includes registered nurses, pharmacists, and medical writers who specialize in translating complex medical information into clear, actionable guidance for patients.

    Editorial Standards

    Trimi publishes patient education using a medical-review workflow, source-based claim checks, and dated updates for fast-changing pricing, access, and safety topics.

    Review our Editorial Policy and Medical Review Policy for more details about sourcing, updates, and reviewer attribution.

    Was this article helpful?

    Keep Reading

    Read our guide on Can Glp 1 Reduce Cancer Risk.

    Read our guide on Sarcopenia Risk Glp 1.

    Read our guide on Glp 1 Success Post Pregnancy.

    Read our guide on Retatrutide Compounding Quality.